New Framework Improves Nanophotonic Biosensing Performance

CHENGDU, SICHUAN, CHINA, October 13, 2026 /CourierPR/ -- Beijing Information Science and Technology University has introduced a new framework for evaluating nanophotonic biosensors, aiming to improve the practical performance of these devices in complex biological environments. The research, published in Opto-Electronic Advances on June 09, 2026, proposes a Mode, Interface, Measurement, Decision (MIMD) framework to reinterpret nanophotonic biosensing as a complete information-transfer process.

Traditional evaluation metrics for nanophotonic biosensors, such as sensitivity, quality factor, linewidth, and detection limit, often fall short in practical applications. These metrics, while useful in ideal laboratory conditions, do not fully capture the challenges faced in real-world biological samples. The MIMD framework addresses this gap by emphasizing the entire process from the generation of biological information to the final decision-making step.

The Mode layer defines the location and interaction of the optical field with matter, including field confinement, evanescent-field depth, resonance linewidth, phase response, and mode accessibility. The Interface layer focuses on the conversion of biological recognition into a local optical perturbation, involving receptor immobilization, linker chemistry, antifouling design, analyte accessibility, transport, molecular orientation, steric effects, and nonspecific adsorption. The Measurement layer specifies how the optical perturbation is extracted, with different systems reading out resonance-angle shifts, wavelength shifts, intensity changes, phase variations, interferometric contrast, Raman intensity, scattering spectra, or spatial image patterns. The Decision layer defines the ultimate use of the signal, such as concentration estimation, kinetic analysis, molecular identification, sample classification, and task-specific judgment.

The research team, led by Professor Jiaming Lyu, has published nine SCI papers in high-level journals, including Opto-Electronic Advances, Light, and PhotoniX. One of their papers has been recognized as a Top 0.1% Highly Cited research. The team's technological achievements have received significant recognition, including a First Prize in the Invention category from the Ministry of Education, a First Prize from the Chinese Society for Optical Engineering, and a Silver Medal at the Geneva International Exhibition of Inventions. They have also led or participated in seven projects, including national-level projects, major provincial and ministerial projects, and technology commercialization projects, with total funding exceeding RMB 10 million.

The MIMD framework reinterprets advances in nanophotonic biosensing, such as surface plasmon resonance (SPR), localized surface plasmon resonance (LSPR), surface-enhanced Raman spectroscopy (SERS), photonic crystal sensors, metasurfaces, and metamaterial biosensors. It highlights the importance of optimizing the entire system, from optical modes and interfaces to measurement schemes and decision algorithms, to ensure robust and reliable biosensing performance in complex samples.

The future of nanophotonic biosensing, according to the researchers, will move from simple linear transduction toward hierarchical information readout. Traditional linear channels, such as refractive-index-induced resonance shifts, will remain valuable for their robustness and scalability. However, future systems may combine linear detection with nonlinear, inelastic, spectroscopic, imaging-based, and data-driven channels, including SERS, second-harmonic generation, fluorescence correlation spectroscopy, and machine-learning-assisted interpretation. Such layered architectures could support more reliable decision-making in complex samples.

This work marks a significant shift in the evaluation standard of nanophotonic biosensing, emphasizing the importance of cross-layer information fidelity. It provides a more complete design philosophy for next-generation biosensors, where optical structures, biointerfaces, measurement schemes, and decision algorithms should be optimized together. This system-level approach may accelerate the translation of nanophotonic biosensors from laboratory demonstrations to practical tools for healthcare, environmental monitoring, food safety, and point-of-care diagnostics.